Hitoshi Katai
Japanese surgeon who led JCOG0912, the trial that confirmed laparoscopic gastrectomy is not inferior to open surgery for early stomach cancer.
Overview
Hitoshi Katai is a gastric surgeon at the National Cancer Center Hospital in Tokyo. He was first author of the 2020 Lancet Gastroenterology and Hepatology report of JCOG0912, the Japan Clinical Oncology Group trial that showed laparoscopy-assisted distal gastrectomy was non-inferior to open distal gastrectomy for clinical stage I gastric cancer in relapse-free survival.
Similar pages
not linked directly; found by shared links- PersonHyung-Ho Kim
Shares Early gastric cancer, Gastric & gastro-oesophageal junction cancer and the tags gastric, surgery, trialist.
- PersonPeter Thuss-Patience
Shares Gastric & gastro-oesophageal junction cancer and the tags gastric, trialist.
- PersonHansjochen Wilke
Shares Gastric & gastro-oesophageal junction cancer and the tags gastric, trialist.
- PersonManish A. Shah
Shares Gastric & gastro-oesophageal junction cancer and the tags gastric, trialist.
- TrialKLASS-01
Shares JCOG0912: laparoscopy-assisted versus open distal gastrectomy for clinical stage IA or IB gastric cancer, Early gastric cancer, Gastric & gastro-oesophageal junction cancer.
- PersonMitsuru Sasako
Shares Gastric & gastro-oesophageal junction cancer and the tags gastric, surgery.
- PersonSalah-Eddin Al-Batran
Shares Gastric & gastro-oesophageal junction cancer and the tags gastric, trialist.
- PersonZev A. Wainberg
Shares Gastric & gastro-oesophageal junction cancer and the tags gastric, trialist.